Search results
62 Results for 'Women's Health'
- Technologies (37)
- Collaborations (0)
- Team (0)
- News (15)
- Pages (0)
- Multimedia (10)
- Publications (0)
- Jobs (0)
- Events (0)
Technologies 37
-
ReConstruct: Vascularized tissue for breast reconstruction and augmentation
ReConstruct is a platform for growing, vascularizing, and implanting patient-derived tissues that enable safer breast reconstruction after cancer surgery. -
Lactation Biologics: Increasing Milk Production for Healthier Babies
Lactation Biologics is developing a long-lasting, self-injectable treatment to help nursing mothers feed their babies naturally, helping them get the best nutrition possible in the face of climate disasters and supply chain disruptions. -
Human Ovarian Organoids to Improve Women’s Health
Gameto is using the Wyss Institute’s fully human ovarian organoid technology to solve the global problem of rising infertility by making IVF safer, cheaper, and more accessible. -
CogniXense for Rare Disease Drug Discovery
Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome. -
LactoRING for a Healthy Vaginal Microbiome
LactoRING is a novel slow-release vaginal ring designed to ensure continuous replenishment of Lactobacillus, promoting a healthy vaginal microbiome for a longer duration. The slow-release mechanism and targeted delivery to the vaginal environment will enhance the efficacy and convenience of treatment, thereby providing a comprehensive approach to vaginal dysbiosis management. -
Human Organs-on-Chips
Organ Chips are microfluidic devices lined with living human cells for drug development, disease modeling, and personalized medicine. Launched in 2014, Wyss startup Emulate, Inc., is leveraging the Wyss Institute’s Organ Chip technology to mimic human organs in vitro, enabling faster, better, and cheaper drug development and insights into human health.
News 15
Multimedia 10
-
Video/AnimationProgress, Potential, and Possibilities with Luba Perry, Ph.D. – Bioengineered Breast Reconstruction And AugmentationEach episode of this podcast includes a discussion with fascinating people designing a better tomorrow. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio, an innovative venture emerging from Harvard’s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and... -
Video/AnimationMice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald IngberIn this episode, host Sharon Kedar, Co-Founder of Northpond Ventures, is joined by Dr. Donald Ingber, Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University. Dr. Ingber’s commitment to following his passion has led him to countless medical and technological breakthroughs, including Organ Chip technology. These incredible chips recreate the structure and... -
Video/AnimationAtlantic Health Research Spotlight: Female-Reproductive-Tract Organ Chips for Women’s Health and Fertility StudiesInnovation has disrupted care as we know it. Challenges with access, complex diseases, and care delivery persist, but so do areas of opportunity for emerging tech and discoveries. The Atlantic explored gene editing, artificial intelligence, climate change, weight-loss and diabetes treatments, and more at their annual Health Summit. Wyss researchers Aakanksha Gulati, Ph.D., and Ola... -
Video/AnimationReimagine the World – Volume 4 – ReConstruct EditionDenise Skok, a two-time breast cancer survivor, Luba Perry, a scientist at the Wyss Institute, and Samuel Lin, a plastic surgeon collaborating with the Wyss Institute, are all working to reimagine a world where breast cancer patients have better reconstruction options. The ReConstruct project at the Wyss Institute uses adipose tissue assembled from a patient’s... -
Video/AnimationEnhancing Lactation to Improve Infant and Maternal HealthLactation Biologics is developing a long-lasting, self-injectable treatment to help nursing mothers feed their babies naturally, helping them get the best nutrition possible in the face of climate disasters and supply chain disruptions. Credit: Wyss Institute at Harvard University -
Video/AnimationReimagining Healthcare for Women – 52% of All PatientsDr. Kathryn Rexrode, Division Chief of Women’s Health at Brigham and Women’s Hospital, discusses gender and biological sex-based discrimination in medicine, the profound effect that gender and biological sex has on healthcare, the short falls in women’s health research, and why she is hopeful that healthcare will improve for women. Credit: Wyss Institute at Harvard...